These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Malignant pleural mesothelioma presenting as low back pain: diagnosed by bone scan coordinating with F-18 FDG PET/CT. Huang YC; Tu DG; Wu JD; Lee MY Spine (Phila Pa 1976); 2009 Oct; 34(21):E780-3. PubMed ID: 19934799 [TBL] [Abstract][Full Text] [Related]
3. Pseudomesotheliomatous lung cancer mimicking mesothelioma on ¹⁸F-FDG PET/CT images: report of 2 cases. Nakamori T; Kosuda S; Kyoto Y; Fujikawa A; Naoi Y; Nakamori Y Jpn J Radiol; 2013 Aug; 31(8):542-5. PubMed ID: 23620108 [TBL] [Abstract][Full Text] [Related]
4. Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study. Yildirim H; Metintas M; Entok E; Ak G; Ak I; Dundar E; Erginel S J Thorac Oncol; 2009 Dec; 4(12):1480-4. PubMed ID: 19875971 [TBL] [Abstract][Full Text] [Related]
5. The role of FDG PET-CT in differential diagnosis of pleural pathologies. Elboga U; Yılmaz M; Uyar M; Zeki Çelen Y; Bakır K; Dikensoy O Rev Esp Med Nucl Imagen Mol; 2012; 31(4):187-91. PubMed ID: 23067687 [TBL] [Abstract][Full Text] [Related]
6. Paget disease of the humerus mimicking metastatic disease in a patient with metastatic malignant mesothelioma on whole body F-18 FDG PET/CT. Mahmood S; Martinez de Llano SR Clin Nucl Med; 2008 Jul; 33(7):510-2. PubMed ID: 18580246 [TBL] [Abstract][Full Text] [Related]
7. F-18 fluorodeoxyglucose PET/CT scanning in the diagnostic work-up of a primary pericardial mesothelioma: a case report. Ost P; Rottey S; Smeets P; Boterberg T; Stragier B; Goethals I J Thorac Imaging; 2008 Feb; 23(1):35-8. PubMed ID: 18347518 [TBL] [Abstract][Full Text] [Related]
8. Patterns of disease progression on 18F-fluorodeoxyglucose positron emission tomography-computed tomography in patients with malignant pleural mesothelioma undergoing multimodality therapy with pleurectomy/decortication. Bille A; Chicklore S; Okiror L; Cook GJ; Spicer J; Landau D; Lang-Lazdunski L Nucl Med Commun; 2013 Nov; 34(11):1075-83. PubMed ID: 23963351 [TBL] [Abstract][Full Text] [Related]
9. Does positron emission tomography offer prognostic information in malignant pleural mesothelioma? Sharif S; Zahid I; Routledge T; Scarci M Interact Cardiovasc Thorac Surg; 2011 May; 12(5):806-11. PubMed ID: 21266493 [TBL] [Abstract][Full Text] [Related]
10. Clinical implications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma. Abe Y; Tamura K; Sakata I; Ishida J; Ozeki Y; Tamura A; Uematsu K; Sakai H; Goya T; Kanazawa M; Machida K Oncol Rep; 2012 Feb; 27(2):333-8. PubMed ID: 22024889 [TBL] [Abstract][Full Text] [Related]
11. 18-FDG positron emission tomography in the evaluation of malignant pleural diseases - a pilot study. Carretta A; Landoni C; Melloni G; Ceresoli GL; Compierchio A; Fazio F; Zannini P Eur J Cardiothorac Surg; 2000 Apr; 17(4):377-83. PubMed ID: 10773558 [TBL] [Abstract][Full Text] [Related]
12. Non-small cell lung cancer: evaluation of pleural abnormalities on CT scans with 18F FDG PET. Schaffler GJ; Wolf G; Schoellnast H; Groell R; Maier A; Smolle-Jüttner FM; Woltsche M; Fasching G; Nicoletti R; Aigner RM Radiology; 2004 Jun; 231(3):858-65. PubMed ID: 15105451 [TBL] [Abstract][Full Text] [Related]
13. [F-18-FDG PET for primary diagnosis differential diagnosis of pleural processes]. Buchmann I; Guhlmann CA; Elsner K; Gfrörer W; Schirrmeister H; Kotzerke J; Buck A; Reske SN Nuklearmedizin; 1999; 38(8):319-22. PubMed ID: 10615665 [TBL] [Abstract][Full Text] [Related]
14. Role of integrated 18-fluorodeoxyglucose position emission tomography-computed tomography in patients surveillance after multimodality therapy of malignant pleural mesothelioma. Tan C; Barrington S; Rankin S; Landau D; Pilling J; Spicer J; Cane P; Lang-Lazdunski L J Thorac Oncol; 2010 Mar; 5(3):385-8. PubMed ID: 20087231 [TBL] [Abstract][Full Text] [Related]
15. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients. Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344 [TBL] [Abstract][Full Text] [Related]
16. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas. Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094 [TBL] [Abstract][Full Text] [Related]
17. Integrated positron emission tomography-computed tomography does not accurately stage intrathoracic disease of patients undergoing trimodality therapy for malignant pleural mesothelioma. Pilling J; Dartnell JA; Lang-Lazdunski L Thorac Cardiovasc Surg; 2010 Jun; 58(4):215-9. PubMed ID: 20514576 [TBL] [Abstract][Full Text] [Related]
18. Pleural tuberculosis mimicking malignant pleural mesothelioma by Ai L; Wang W; Li Y Med Clin (Barc); 2023 Nov; 161(9):415. PubMed ID: 37263842 [No Abstract] [Full Text] [Related]